Business News

Insmed Names New CFO


Insmed, a biopharmaceutical company, named Paolo Tombesi as chief financial officer, effective June 1, and Paul Streck, as chief medical officer, effective June 5. Additionally, Eugene Sullivan, has been appointed to the newly created role of chief product strategy officer. Tombesi brings over 20 years of experience in the biotechnology and pharmaceutical sector, most recently serving as vice president and chief financial and administrative officer of Novartis Pharmaceuticals, a unit of Swiss drugmaker Novartis (NVS).

Dr. Streck joins Insmed with over 25 years of clinical development, management and leadership expertise. He most recently served as vice president, global medical specialty franchise, Immuno-inflammation at GlaxoSmithKline (GSK). Dr. Sullivan joined Insmed as chief medical and scientific officer in 2015, and has more than 20 years of experience with a focus on pulmonary and orphan diseases.